Đang chuẩn bị liên kết để tải về tài liệu:
Quality of life analyses in patients with multiple myeloma: Results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Selinexor is an oral, selective nuclear export inhibitor. STORM was a phase 2b, single-arm, open-label, multicenter trial of selinexor with low dose dexamethasone in patients with penta-exposed relapsed/refractory multiple myeloma (RRMM) that met its primary endpoint, with overall response of 26% (95% confidence interval [CI], 19 to 35%). |

TÀI LIỆU LIÊN QUAN

The life in sight application study (LISA): Design of a randomized controlled trial to assess the role of an assisted structured reflection on life events and ultimate life goals to improve quality of life of cancer patients

Assessment of quality of life and the effective use of inhaled bronchodilator medication by patients, suffering from asthma Quality of life & Asthma

Improving quality of life of rural women through dairying in Bihar

Factors associated with quality of life among elderly in urban Vietnam

The impacts of tourism on life quality in the community: Case of Cu Chi, Ho Chi Minh city

Information system quality in work-life balance

Metabolic correlates of health-related quality of life among overweight and obese adolescents

The comparison of perceived health-related quality of life between Australian children with severe specific language impairment to age and gender-matched peers

Is utility-based quality of life associated with overweight in children? Evidence from the UK WAVES randomised controlled study

The impacts of tourism on life quality in the community: Case of Cu Chi, Hochiminh city
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.